Company Filing History:
1 out of 181 
1 out of 49 Years Active: 2006-2009
Title: Hwan-Wun Liu: Innovator in Medical Treatments
Introduction
Hwan-Wun Liu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical treatments, particularly in addressing viral infections and developing novel proteins.
Latest Patents
Hwan-Wun Liu holds 2 patents. His latest patents include a method for treating coronavirus infection by administering an effective amount of various compounds. These compounds include aklavin, sanguinarine, amiodarone, chlorpromazine, and many others. Additionally, he has developed nucleic acid molecules and polypeptides related to h-ADAM7, which includes the novel GP-83 protein and its associated nucleic acid molecules.
Career Highlights
Throughout his career, Hwan-Wun Liu has worked with esteemed organizations such as the National Health Research Institutes and the National Defense Medical Center. His work has focused on innovative solutions to pressing health issues, particularly in the realm of infectious diseases.
Collaborations
Hwan-Wun Liu has collaborated with notable colleagues, including Tsu-An Hsu and Hsing-Pang Hsieh. Their combined expertise has contributed to advancements in medical research and treatment methodologies.
Conclusion
Hwan-Wun Liu's contributions to medical innovation, particularly in the treatment of viral infections and the development of novel proteins, highlight his role as a significant figure in the field. His work continues to impact the medical community positively.